TABLE 1.
Selected Patient Characteristics
| Patient Characteristics | Frequency (n) | % |
|---|---|---|
| Age category | ||
| 46–56 y | 4 | 10.53 |
| 57–67 y | 13 | 34.21 |
| 68–78 y | 19 | 50 |
| 79–89 y | 2 | 5.26 |
| Age at diagnosis | ||
| 45–55 y | 3 | 9.68 |
| 56–66 y | 12 | 38.71 |
| 67–77 y | 16 | 51.61 |
| Stage of cancer at diagnosis | ||
| 1 (unspecified) | 1 | 2.78 |
| 2 (unspecified) | 1 | 2.78 |
| 2A | 5 | 13.89 |
| 2B | 5 | 13.89 |
| 2C | 1 | 2.78 |
| 3 (unspecified) | 2 | 5.56 |
| 3A | 13 | 36.11 |
| 3B | 2 | 5.56 |
| 4 (unspecified) | 3 | 8.33 |
| 4A | 1 | 2.78 |
| 4B | 2 | 5.56 |
| PSA level | ||
| 1 (0–9.9 ng/mL) | 6 | 15.79 |
| 2 (10–20 ng/mL) | 10 | 26.32 |
| 3 (>20 ng/mL) | 22 | 57.89 |
| Gleason score | ||
| ≤6 (low risk) | 7 | 18.42 |
| 7 (intermediate risk | 21 | 55.26 |
| 8–10 (high risk) | 10 | 26.32 |